Warrior Rectal Care

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Warrior Rectal Care
Generic name: LIDOCAINE 4%, PHENYLEPHRINE HYDROCHLORIDE 0.25%
Manufacturer: Derma Care Research Labs
Product type: HUMAN OTC DRUG
SPL set ID: fc10cbc3-fc1b-ae09-e053-6394a90ac8f3
SPL ID: 295941e8-0c67-8b8f-e063-6394a90aac09
Version: 2
Effective date: 2024-12-15
Source export date: 2026-09-28
Source partition: 11
Source file: https://download.open.fda.gov/drug/label/drug-label-0011-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/aa96b5a2be6b394393acd0090f6948bdf99e0e8e00666f81608929c8fa83db77/drug-label-0011-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 06:18:49

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M015	openfda.application_number
brand name		Warrior Rectal Care	openfda.brand_name
generic name		LIDOCAINE 4%, PHENYLEPHRINE HYDROCHLORIDE 0.25%	openfda.generic_name
manufacturer name		Derma Care Research Labs	openfda.manufacturer_name
ndc	package	72839-071-01	openfda.package_ndc
ndc	product	72839-071	openfda.product_ndc
ndc11	package	72839007101	derived:openfda.package_ndc
spl id		295941e8-0c67-8b8f-e063-6394a90aac09	id
spl set id		fc10cbc3-fc1b-ae09-e053-6394a90ac8f3	set_id
unii		98PI200987	openfda.unii
unii		04JA59TNSJ	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

For external and/or intrarectal use only. When using this product do not exceed recommended daily dosage unless directed by a doctor. Do not use this product if you have difficulty in urination due to enlargement of the prostate gland. Diabetes, heart disease, high blood pressure, thyroid disease. Presently taking a prescription for high blood pressure or depression. Stop use and ask a doctor if condition worsens or does not improve within seven days, bleeding occurs. Introduction of applicator into the rectum causes additional pain.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.